Netherlands Respiratory Devices Market

Netherlands Respiratory Devices Market by Device Types (Diagnostic and Monitoring Devices, [Spirometers, Sleep Test Devices, Peak Flow Meters, and Others], Therapeutic Devices [Ventilators, Inhalers, CPAP Devices, and Others], and Disposables [Masks, Breathing Circuits, and Others}), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3565
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 196
  • Format:
  • Pub. Date: Upcoming
  • Share:

The Netherlands respiratory devices market size is projected to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to Increase in prevalence of respiratory diseases.


Netherlands Respiratory Devices Market summary

Respiratory devices are clinical devices that are utilized to help patients who are suffering from respiratory issues and can't achieve sufficient oxygen levels to support life. Chronic respiratory diseases are chronic diseases that affect the airways and different parts of the lungs. A portion of the major preventable chronic respiratory disorders include chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and tuberculosis.

As per the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is a major health concern and is one of the major causes of death worldwide. Technologically advanced medical devices and effective medications have become key to the management of COPD and other respiratory disorders. In the current healthcare scenario, respiratory health is of paramount importance. For instance, asthma is a serious debilitating disease, and thus requires the administration of treatment drugs for asthma.

The COVID-19 virus has tainted more than a quarter of a million people internationally.  With the proceeded spread of this infection that can cause pneumonia and difficulty in breathing, hospitals are facing a limited supply of ventilators. The impact of the COVID-19 crisis is expected to further accelerate the growth of the respiratory devices market.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing number of emergency hospitals with medical devices & surgical equipment is expected to boost the respiratory devices market.
  • Growing demand for respiratory devices is expected to boost the market.
  • Rising pollution level and growth in geriatric population are estimated to accelerate the growth of the market.
  • Increasing technological innovation in developed countries are key factors driving the market growth.
  • High cost burden of respiratory diseases can restrain the growth of the market.
  • Government initiatives for the launch and approval of these devices further can fuel the market growth.

Scope of the Report                          

The report on the Netherlands respiratory devices market includes an assessment of the market, trends, segments, and geography markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Respiratory Devices Market - Netherlands Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Diagnostic and Monitoring Devices [Spirometers, Sleep Test Devices, Peak Flow Meters, and Others], Therapeutic Devices [Ventilators, Inhalers, CPAP Devices and Others], and Disposables {Masks, Breathing Circuits, and Others})

Country Scope

The Netherlands

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

GlaxoSmithKline PLC; DeVilbiss Healthcare LLC,; GE Healthcare;  Dragerwerk AG, ; Fisher & Paykel Healthcare Ltd,;   and Getinge AB.

Respiratory Devices Market Segment Insights

Therapeutic devices segment is expected to grow at a rapid pace

Based on types, the market is divided into diagnostic and monitoring devices, therapeutic devices and disposables. The diagnostic and monitoring devices segment is further classified as spirometers, sleep test devices, peak flow meters, and others. The therapeutic devices segment is further segmented into ventilators, inhalers, CPAP devices, and others. The disposables segment is further segmented into masks, breathing circuits, and others. The ventilators sub-segment is estimated to account for a significant share of the market.  Ventilators demand has been steadily increasing due to the increasing prevalence of chronic diseases and aging populations across the globe. On other hand, the continuous COVID-19 supply challenges has increased the demand for ventilators.


Netherlands Respiratory Devices Market types

Segments

Segments Covered in the Report
The Netherlands respiratory devices market has been segmented on the basis of
Types

  • Diagnostic and Monitoring Devices
    • Spirometers
    • Sleep Test Devices
    • Peak Flow Meters
    • Others
  • Therapeutic Devices
    • Ventilators
    • Inhalers
    • CPAP Devices
    • Others
  • Disposables
    • Masks
    • Breathing Circuits
    • Others

Country

  • The Netherlands

Key Players

  • GlaxoSmithKline PLC
  • DeVilbiss Healthcare LLC
  • GE Healthcare
  • Dragerwerk AG
  • Fisher & Paykel Healthcare Ltd
  • Getinge AB

 

Competitive Landscape

Key players competing in the Netherlands respiratory devices market are GlaxoSmithKline PLC; DeVilbiss Healthcare LLC; GE Healthcare; Dragerwerk AG; Fisher & Paykel Healthcare Ltd; and Getinge AB. The market players are continuously indulging in the activities such as mergers and acquisitions, research and developments, and increasing their investments for development of innovative products.

In April 2019, Boehringer Ingelheim International GmbH contributed EUR 105 million to extend its creation sites in Dortmund and Ingelheim in Germany for improvement of respiratory pipeline items. This venture and extension can support the creation limit of cutting edge inhaler Respimat in Europe.

In September 2019, GlaxoSmithKline plc reported the US Food and Drug Administration (FDA) endorsement for its biologics Nucala (mepolizumab) for the treatment of serious eosinophilic asthma in children aged somewhere in the range of  six and 11. This approval has extended the extra treatment for serious eosinophilic asthma in the US for patients.

Netherlands Respiratory Devices Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Respiratory Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Respiratory Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Respiratory Devices Market - Supply Chain
  4.5. Global Respiratory Devices Market Forecast
     4.5.1. Respiratory Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Respiratory Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Respiratory Devices Market Absolute $ Opportunity
5. Global Respiratory Devices Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Respiratory Devices Market Size and Volume Forecast by Types
     5.3.1. Diagnostic and Monitoring Devices
     5.3.2. Therapeutic Devices
     5.3.3. Disposables
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Respiratory Devices Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Respiratory Devices Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Respiratory Devices Demand Share Forecast, 2019-2026
7. North America Respiratory Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Respiratory Devices Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Respiratory Devices Market Size and Volume Forecast by Types
     7.4.1. Diagnostic and Monitoring Devices
     7.4.2. Therapeutic Devices
     7.4.3. Disposables
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Respiratory Devices Demand Share Forecast, 2019-2026
8. Latin America Respiratory Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Respiratory Devices Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Respiratory Devices Market Size and Volume Forecast by Types
     8.4.1. Diagnostic and Monitoring Devices
     8.4.2. Therapeutic Devices
     8.4.3. Disposables
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Respiratory Devices Demand Share Forecast, 2019-2026
9. Europe Respiratory Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Respiratory Devices Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Respiratory Devices Market Size and Volume Forecast by Types
     9.4.1. Diagnostic and Monitoring Devices
     9.4.2. Therapeutic Devices
     9.4.3. Disposables
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Respiratory Devices Demand Share Forecast, 2019-2026
10. Asia Pacific Respiratory Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Respiratory Devices Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Respiratory Devices Market Size and Volume Forecast by Types
     10.4.1. Diagnostic and Monitoring Devices
     10.4.2. Therapeutic Devices
     10.4.3. Disposables
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Respiratory Devices Demand Share Forecast, 2019-2026
11. Middle East & Africa Respiratory Devices Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Respiratory Devices Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Respiratory Devices Market Size and Volume Forecast by Types
     11.4.1. Diagnostic and Monitoring Devices
     11.4.2. Therapeutic Devices
     11.4.3. Disposables
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Respiratory Devices Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Respiratory Devices Market: Market Share Analysis
  12.2. Respiratory Devices Distributors and Customers
  12.3. Respiratory Devices Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. GlaxoSmithKline PLC
     12.4.2. DeVilbiss Healthcare LLC
     12.4.3. GE Healthcare
     12.4.4. Dragerwerk AG
     12.4.5. Fisher & Paykel Healthcare Ltd
     12.4.6. Getinge AB.

Segments Covered in the Report
The Netherlands respiratory devices market has been segmented on the basis of
Types

  • Diagnostic and Monitoring Devices
    • Spirometers
    • Sleep Test Devices
    • Peak Flow Meters
    • Others
  • Therapeutic Devices
    • Ventilators
    • Inhalers
    • CPAP Devices
    • Others
  • Disposables
    • Masks
    • Breathing Circuits
    • Others

Country

  • The Netherlands

Key Players

  • GlaxoSmithKline PLC
  • DeVilbiss Healthcare LLC
  • GE Healthcare
  • Dragerwerk AG
  • Fisher & Paykel Healthcare Ltd
  • Getinge AB

 

Key players competing in the Netherlands respiratory devices market are GlaxoSmithKline PLC; DeVilbiss Healthcare LLC; GE Healthcare; Dragerwerk AG; Fisher & Paykel Healthcare Ltd; and Getinge AB. The market players are continuously indulging in the activities such as mergers and acquisitions, research and developments, and increasing their investments for development of innovative products.

In April 2019, Boehringer Ingelheim International GmbH contributed EUR 105 million to extend its creation sites in Dortmund and Ingelheim in Germany for improvement of respiratory pipeline items. This venture and extension can support the creation limit of cutting edge inhaler Respimat in Europe.

In September 2019, GlaxoSmithKline plc reported the US Food and Drug Administration (FDA) endorsement for its biologics Nucala (mepolizumab) for the treatment of serious eosinophilic asthma in children aged somewhere in the range of  six and 11. This approval has extended the extra treatment for serious eosinophilic asthma in the US for patients.

Netherlands Respiratory Devices Market keyplayers

Buy Report